Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cance···【more】
Release date：2026-01-08Recommended：33
Ixazomib Citrate is approved for use in combination with lenalidomide and dexame···【more】
Release date：2026-01-08Recommended：30
Ixazomib has been approved by the U.S. Food and Drug Administration (FDA) for th···【more】
Release date：2026-01-08Recommended：37
Ixazomib is available in capsule dosage form and is a prescription-only medicine···【more】
Release date：2026-01-08Recommended：39
Ixazomib is classified as an antineoplastic agent (anticancer drug). Its mechani···【more】
Release date：2026-01-07Recommended：24
Ixazomib, in combination with lenalidomide and dexamethasone, is indicated for t···【more】
Release date：2026-01-07Recommended：24
Ixazomib is a proteasome inhibitor drug. Its mechanism of action is to prevent m···【more】
Release date：2026-01-07Recommended：31
Ixazomib is typically indicated for the treatment of multiple myeloma, a type of···【more】
Release date：2026-01-07Recommended：30
Ixazomib is indicated for the treatment of multiple myeloma. Its mechanism of ac···【more】
Release date：2026-01-07Recommended：27
Ixazomib is a medication indicated for the treatment of multiple myeloma, exerti···【more】
Release date：2026-01-07Recommended：28
Ixazomib is indicated for the treatment of multiple myeloma, a type of bone marr···【more】
Release date：2026-01-07Recommended：25
Ixazomib is a second-generation proteasome inhibitor that has emerged as a pivot···【more】
Release date：2026-01-07Recommended：26
